pmed.1003752.s004.docx (538.66 kB)

Analysis plan.

journal contribution

posted on 2021-09-09, 17:36 authored by Peter MacPherson, Emily L. Webb, Wala Kamchedzera, Elizabeth Joekes, Gugu Mjoli, David G. Lalloo, Titus H. Divala, Augustine T. Choko, Rachael M. Burke, Hendramoorthy Maheswaran, Madhukar Pai, S. Bertel Squire, Marriott Nliwasa, Elizabeth L. Corbett

(DOCX)

History

Usage metrics

Categories

Keywords

high global burden high cad4tbv5 scores 497 randomly allocated 27 november 2019 efficiently improve tb prospect study ):adjusted life year xlink "> dcxr tb screening arms short participant follow 15 november 2018 tb screening arm hiv screening reduced tb versus soc hiv screening arm tb screening participants tb screening ).rr ]: 0 care plus dcxr 11 %), 52 arm randomised trial 38 ), 6 0 %) soc day tb treatment 5 %) participants 0 %) hiv 5 %) hiv effectiveness analysis used 1 %) soc tb screening soc arm hiv screening tb treatment 5 %)day treatment 0 %),tb diagnosis study staff randomised trial life benefits day 56 71 ).03 ).0 %.2 %)untreated hiv systematic hiv hiv testing hiv diagnosis hiv contribute 87 ),22 ),9 %)ray screening 2 soc 7 %)treat basis sputum xpert risk ratio provider perspective primary outcome main limitations investigator blinding investigated costs intervention allocation incremental costs hazard ratio final analysis aided x 9 %),2 hiv

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC